Ibnsina Pharma (EGX: ISPH)

Ibnsina Pharma Income Statement

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	42,064	33,949	22,264	21,733	18,679	16,600
Revenue Growth (YoY)	57.54%	52.48%	2.45%	16.35%	12.52%	24.59%
Cost of Revenue	38,922	31,434	20,648	20,103	17,212	15,161
Gross Profit	3,143	2,515	1,617	1,630	1,467	1,439
Selling, General & Admin	1,536	1,289	1,076	829.22	822.71	674.71
Other Operating Expenses	0.82	5	-	-	-	10.67
Operating Expenses	1,643	1,378	1,142	962.17	978.17	786.12
Operating Income	1,499	1,137	475.22	667.35	488.69	653.33
Interest Expense	-1,368	-1,044	-477.09	-284.18	-255.32	-252.51
Interest & Investment Income	159.74	126.65	133.26	-	-	-
Earnings From Equity Investments	-1.31	-1.13	-	-	-	-
Currency Exchange Gain (Loss)	53.15	38.53	38.41	0.28	-0.3	-1.57
Other Non Operating Income (Expenses)	7.63	10.37	4.76	86.01	56.73	20.57
EBT Excluding Unusual Items	350.63	267.53	174.55	469.46	289.8	419.82
Gain (Loss) on Sale of Assets	0.48	0.48	0.75	4.25	2.42	1.06
Legal Settlements	-	-	-	-48	-	-
Other Unusual Items	-	-	-	-0.37	-	-
Pretax Income	351.11	268.02	175.31	425.34	292.22	420.88
Income Tax Expense	47.86	54.74	4.43	110.95	67.56	92.11
Earnings From Continuing Operations	303.25	213.27	170.87	314.4	224.66	328.77
Minority Interest in Earnings	-0	0.39	1.71	0.33	-	-
Net Income	303.25	213.66	172.58	314.73	224.66	328.77
Preferred Dividends & Other Adjustments	52.29	40.52	36.95	28.4	40.55	59.34
Net Income to Common	250.97	173.14	135.63	286.33	184.11	269.43
Net Income Growth	40.41%	23.80%	-45.16%	40.09%	-31.67%	25.24%
Shares Outstanding (Basic)	1,008	1,008	1,008	1,302	1,120	1,120
Shares Outstanding (Diluted)	1,008	1,008	1,008	1,302	1,120	1,120
Shares Change (YoY)	-	-	-22.58%	16.25%	-	1.54%
EPS (Basic)	0.25	0.17	0.13	0.22	0.16	0.24
EPS (Diluted)	0.25	0.17	0.13	0.22	0.16	0.24
EPS Growth	48.58%	27.65%	-38.82%	33.78%	-31.67%	9.51%
Free Cash Flow	-236.99	-228.23	-436.58	-487.96	21.75	-380.08
Free Cash Flow Per Share	-0.24	-0.23	-0.43	-0.37	0.02	-0.34
Dividend Per Share	-	-	-	0.086	-	-
Gross Margin	7.47%	7.41%	7.26%	7.50%	7.85%	8.67%
Operating Margin	3.56%	3.35%	2.13%	3.07%	2.62%	3.94%
Profit Margin	0.60%	0.51%	0.61%	1.32%	0.99%	1.62%
Free Cash Flow Margin	-0.56%	-0.67%	-1.96%	-2.25%	0.12%	-2.29%
EBITDA	1,623	1,251	589.26	784.78	601.49	723.44
EBITDA Margin	3.86%	3.69%	2.65%	3.61%	3.22%	4.36%
D&A For EBITDA	124.06	114.18	114.04	117.43	112.8	70.11
EBIT	1,499	1,137	475.22	667.35	488.69	653.33
EBIT Margin	3.56%	3.35%	2.13%	3.07%	2.62%	3.94%
Effective Tax Rate	13.63%	20.43%	2.53%	26.08%	23.12%	21.89%

Source: S&P Capital IQ. Standard template. Financial Sources.